For research use only. Not for therapeutic Use.
Naloxonazine dihydrochloride (Cat.No:I010245) is a selective inhibitor of the enzyme dopamine beta-hydroxylase (DBH). It blocks the conversion of dopamine to norepinephrine, resulting in increased dopamine levels in the brain. Naloxonazine dihydrochloride has been studied for its potential use in treating conditions such as depression and drug addiction by modulating the dopamine system.
| Catalog Number | I010245 |
| CAS Number | 880759-65-9 |
| Synonyms | Bis-[5-α-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)-morphinan-6-ylidene] hydrazine dihydrochloride |
| Molecular Formula | C38H42N4O6.2HCl |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| Solubility | Soluble to 25 mM in water |
| Storage | Store at RT |
